Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Faron

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world dataAlice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2021
Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical CarcinomaAlice Boilève, Elise Mathy, Charles Roux, et al.
Cancers|May 14, 2022
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall SurvivalSegolene Hescot, Matthieu Faron, Manal Kordahi, et al.
Genes, Chromosomes & Cancer|August 6, 2022
A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcomaCarine Ngo, Benjamin Verret, Julien Vibert, et al.
The British Journal of Surgery|November 9, 2023
Image-guided core biopsy for pelvic lesions of unknown originCamille Batlle, Matthieu Faron, Frédéric Deschamps, et al.
Annals of Surgical Oncology|December 3, 2014
Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastasesMarc Antoine Allard, Mylène Sebagh, Gaëlle Baillie, et al.
Endocrine|August 28, 2023
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational studyFrancisca Marques Puga, Abir Al Ghuzlan, Dana M Hartl, et al.
Neuroendocrinology|October 23, 2019
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?Julien Hadoux, Pierre Blanchard, Jean-Yves Scoazec, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 25, 2020
Postoperative Outcome of Surgery with Pancreatic Resection for Retroperitoneal Soft Tissue Sarcoma: Results of a Retrospective Bicentric Analysis on 50 Consecutive PatientsMeredith Flacs, Matthieu Faron, Olivier Mir, et al.
European Radiology|July 30, 2024
Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion ChemotherapyLouis Meyblum, Matthieu Faron, Frédéric Deschamps, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world dataAlice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2021
Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical CarcinomaAlice Boilève, Elise Mathy, Charles Roux, et al.
Cancers|May 14, 2022
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall SurvivalSegolene Hescot, Matthieu Faron, Manal Kordahi, et al.
Genes, Chromosomes & Cancer|August 6, 2022
A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcomaCarine Ngo, Benjamin Verret, Julien Vibert, et al.
The British Journal of Surgery|November 9, 2023
Image-guided core biopsy for pelvic lesions of unknown originCamille Batlle, Matthieu Faron, Frédéric Deschamps, et al.
Annals of Surgical Oncology|December 3, 2014
Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastasesMarc Antoine Allard, Mylène Sebagh, Gaëlle Baillie, et al.
Endocrine|August 28, 2023
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational studyFrancisca Marques Puga, Abir Al Ghuzlan, Dana M Hartl, et al.
Neuroendocrinology|October 23, 2019
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?Julien Hadoux, Pierre Blanchard, Jean-Yves Scoazec, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 25, 2020
Postoperative Outcome of Surgery with Pancreatic Resection for Retroperitoneal Soft Tissue Sarcoma: Results of a Retrospective Bicentric Analysis on 50 Consecutive PatientsMeredith Flacs, Matthieu Faron, Olivier Mir, et al.
European Radiology|July 30, 2024
Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion ChemotherapyLouis Meyblum, Matthieu Faron, Frédéric Deschamps, et al.
Pageof 10